Skip to main content
. 2022 Feb 15;55(10):1311–1319. doi: 10.1111/apt.16816

TABLE 2.

Characteristics of individuals with Rome IV IBS willing to accept above median risk of death in return for cure of IBS symptoms from a hypothetical medication compared with median or below median risk of death

Above median risk of death

(n = 356)

Median or below median risk of death

(n = 396)

P value*
Female (%) 295 (82.9) 360 (90.9) 0.001
Mean age (SD) 45.7 (14.7) 45.0 (14.9) 0.54
White ethnicity (%) 346 (97.2) 383 (96.7) 0.71
Married (%) 216 (60.7) 270 (68.4) 0.03
Smoker (%) 45 (12.6) 37 (9.3) 0.15
Alcohol user (%) 200 (56.2) 239 (60.4) 0.25
University or postgraduate level of education (%) 140 (39.3) 174 (43.9) 0.20
Annual income of £30,000 or more (%) 102 (31.1) 95 (27.0) 0.24
IBS subtype (%)
IBS‐C 55 (15.5) 81 (20.8)
IBS‐D 146 (41.2) 160 (41.1)
IBS‐M 153(43.2) 148 (38.0) 0.13
Most troublesome symptom (%)
Abdominal pain 87 (24.4) 82 (20.7)
Constipation 26 (7.3) 27 (6.8)
Diarrhoea 62 (17.4) 55 (13.9)
Bloating/distension 92 (25.8) 126 (31.8)
Urgency 89 (25.0) 106 (26.8) 0.26
Continuous abdominal pain (%) 189 (53.1) 156 (39.4) <0.001
Self‐rated risk‐taking behaviour (%)
Never 21 (5.9) 45 (11.4)
Rarely 153 (43.0) 190 (48.0)
Occasionally 171 (48.0) 152 (38.4)
Routinely 11 (3.1) 9 (2.3) 0.008
Duration of IBS diagnosis, year(s) (%)
1 9 (2.5) 16 (4.0)
2 16 (4.5) 25 (6.3)
3 28 (7.9) 26 (6.6)
4 13 (3.7) 20 (5.1)
5 20 (5.6) 18 (4.5)
>5 270 (75.8) 291 (73.5) 0.51
Number of IBS drugs in the last 12 months (%)
0 40 (11.2) 56 (14.1)
1 80 (22.5) 109 (27.5)
2 90 (25.3) 106 (26.8)
3 69 (19.4) 60 (15.2)
4 41 (11.5) 35 (8.8)
≥5 36 (10.1) 30 (7.6) 0.16
IBS‐SSS severity (%)
Mild 33 (9.3) 53 (13.4)
Moderate 132 (37.1) 168 (42.4)
Severe 189 (53.1) 170 (42.9) 0.02
HADS anxiety categories (%)
Normal 84 (23.6) 116 (29.3)
Borderline abnormal 83 (23.3) 91 (23.0)
Abnormal 189 (53.1) 189 (47.7) 0.19
HADS depression categories (%)
Normal 171 (48.0) 233 (58.8)
Borderline abnormal 81 (22.8) 84 (21.2)
Abnormal 104 (29.2) 79 (19.9) 0.004
PHQ‐12 severity (%)
Low 16 (4.5) 20 (5.1)
Mild 81 (22.8) 95 (24.0)
Moderate 132 (37.1) 175 (44.2)
Severe 127 (35.7) 106 (26.8) 0.06
VSI scores (%)
Low 101 (28.4) 146 (36.9)
Medium 118 (33.1) 129 (32.6)
High 137 (38.5) 121 (30.6) 0.02
IBS‐QOL score (%)
Low 133 (37.4) 106 (26.8)
Medium 124 (34.8) 128 (32.3)
High 99 (27.8) 162 (40.9) <0.001
WPAI: IBS, median % (IQR)
Absenteeism 0.0 (0.0‐5.1) 0.0 (0.0‐1.3) 0.10
Presenteeism 40.0 (20.0‐60.0) 30.0 (10.0‐60.0) 0.002
Overall work impairment 40.0 (15.9‐65.3) 30.0 (10.0‐57.1) 0.004
Activity impairment 50.0 (30.0‐70.0) 40.0 (20.0‐60.0) <0.001
*

P value for Pearson χ2 for comparison of categorical data, independent samples t‐test for age, and Mann‐Whitney U test for all four dimensions of Work Productivity and Activity Impairment: Irritable Bowel Syndrome.